Company Filing History:
Years Active: 2017-2019
Title: **Jonathan Toma: Innovator in Co-Receptor Inhibitor Therapy**
Introduction
Jonathan Toma is a noteworthy inventor based in San Francisco, CA. He has made significant contributions to the field of medical innovations, particularly in therapies for HIV treatment. With a total of two patents to his name, Toma is paving the way for improved methodologies in this critical area of healthcare.
Latest Patents
Toma's latest patents focus on compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy. The inventions provide tools to assess if a subject infected with a dual-mixed tropic population of HIV would benefit from either CCR5-inhibitor therapy or CXCR4-inhibitor therapy. The methods include evaluating whether the HIV population is homogeneous or heterogeneous, as this determines the efficacy of co-receptor inhibitor therapy for the patient.
Career Highlights
Jonathan Toma is currently associated with Laboratory Corporation of America Holdings, a prominent company in the healthcare sector. His research and innovations are contributing to advancing therapeutic options for patients facing complex health challenges, particularly in relation to HIV.
Collaborations
While working at Laboratory Corporation of America Holdings, Toma collaborates with various professionals in the field. Notable among his coworkers are Wei Huang and Signe Fransen, who contribute their expertise and work alongside him in developing innovative solutions for healthcare.
Conclusion
Jonathan Toma is an influential inventor making strides in the realm of co-receptor inhibitor therapies for HIV treatment. His patents are a testament to his dedication and innovative spirit, promising advancements that could significantly benefit patients affected by this significant health issue.